Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...
Gaming Industry 9 months after cancelling Transformers: Reactivate, Splash Damage splits from Tencent and is now owned by private equity investors RPG Nightdive Studios says System Shock 2's ...
CNET staff -- not advertisers, partners or business interests -- determine how we review products and services. If you buy through our links, we may earn a commission. A dead car battery is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback